|
skos:definition |
MSH: A vascular endothelial cell growth factor receptor whose expression is restricted primarily to adult lymphatic endothelium. VEGFR-3 preferentially binds the vascular endothelial growth factor C and vascular endothelial growth factor D and may be involved in the control of lymphangiogenesis.,NCI: Fms-related receptor tyrosine kinase 4; endothelial cell-specific receptor; similar to vascular endothelial growth factor VEGF (LocusLink),NCI: Vascular endothelial growth factors, working through VEGF receptor-3 (VEGFR-3), promote angiogenesis and the metastatic spread of cancer cells. (from Nat Med 2001;7:151-152,186-205 via Medscape),NCI: A type I membrane protein tyrosine kinase receptor for VEGF-C, vascular endothelial growth factor receptor 3, contains seven immunoglobulin-like C2-type domains. Vascular endothelial growth factors, working through VEGF receptor-3, promote angiogenesis and metastatic spread of cancer cells. (from Nat Med 2001. 7:151 & 186)
|
